
Sign up to save your podcasts
Or


The SSRI escitalopram beat out a placebo in ameliorating the frequency and severity of hot flashes in menopausal women. Would cheaper SSRIs also do the trick? We talk with the first author of the JAMA paper.
Interview-related links:
By NEJM Group4.5
5656 ratings
The SSRI escitalopram beat out a placebo in ameliorating the frequency and severity of hot flashes in menopausal women. Would cheaper SSRIs also do the trick? We talk with the first author of the JAMA paper.
Interview-related links:

7,598 Listeners

320 Listeners

2,059 Listeners

125 Listeners

497 Listeners

293 Listeners

885 Listeners

263 Listeners

3,341 Listeners

112,032 Listeners

90 Listeners

5 Listeners

92 Listeners

513 Listeners

2,550 Listeners

369 Listeners

15,835 Listeners

61 Listeners

31 Listeners

66 Listeners